Waters Corp. is facing two stockholder lawsuits ahead of its planned $17.5 billion merger with BD's Biosciences & Diagnostic Solutions business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback